Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice
- PMID: 8670812
- PMCID: PMC450254
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice
Abstract
The Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) is a pleiotropic protein which has been characterized extensively both biochemically and functionally. It is the only one of the identified latent protein-encoding genes to be consistently expressed in viral-associated endemic Burkitt's lymphoma cells. As such, it is the only candidate viral protein to possibly perform a maintenance function in the tumour pathology. Despite this, no oncogenic activity has been attributed to the protein in tissue culture assays. The experiments described here were initiated to explore the activity of the protein in B cells in vivo. EBNA-1 transgenic mice were generated with transgene expression directed to the B cell compartment using the mouse Ig heavy chain intron enhancer. Transgene expression was demonstrated in the lymphoid tissues of mice of two independent lines. Transgenic positive mice of both lines succumb to B cell lymphoma. The B cell tumours are monoclonal, frequently of follicular centre cell origin and remarkably similar to those induced by transgenic c-myc expression. These results demonstrate that EBNA-1 is oncogenic in vivo and suggest that the gene product may play a direct role in the pathogenesis of Burkitt's lymphoma and possibly other EBV-associated malignancies.
Similar articles
-
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536. Eur J Immunol. 1995. PMID: 7774641
-
T cell recognition of Epstein-Barr virus associated lymphomas.Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
-
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.J Gen Virol. 1993 Mar;74 ( Pt 3):361-9. doi: 10.1099/0022-1317-74-3-361. J Gen Virol. 1993. PMID: 8383171
-
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.Int Immunol. 1992 Nov;4(11):1283-92. doi: 10.1093/intimm/4.11.1283. Int Immunol. 1992. PMID: 1282031
-
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.J Virol. 1996 Sep;70(9):5758-68. doi: 10.1128/JVI.70.9.5758-5768.1996. J Virol. 1996. PMID: 8709191 Free PMC article.
Cited by
-
Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition.Mol Cancer. 2010 Jul 9;9:184. doi: 10.1186/1476-4598-9-184. Mol Cancer. 2010. PMID: 20618963 Free PMC article.
-
Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice.J Virol. 2008 Apr;82(8):4180-3. doi: 10.1128/JVI.02596-07. Epub 2008 Feb 6. J Virol. 2008. PMID: 18256159 Free PMC article.
-
Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15233-8. doi: 10.1073/pnas.211556598. Epub 2001 Dec 4. Proc Natl Acad Sci U S A. 2001. PMID: 11734622 Free PMC article.
-
Epstein-Barr virus infection and human malignancies.Int J Exp Pathol. 2001 Jun;82(3):149-70. doi: 10.1046/j.1365-2613.2001.iep0082-0149-x. Int J Exp Pathol. 2001. PMID: 11488990 Free PMC article. Review.
-
Prospects of a novel vaccination strategy for human gamma-herpesviruses.Immunol Res. 2010 Dec;48(1-3):122-46. doi: 10.1007/s12026-010-8172-z. Immunol Res. 2010. PMID: 20717741 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials